Su Jin Lee

发表

A target‐mediated drug disposition population pharmacokinetic model of GC1118, a novel anti‐EGFR antibody, in patients with solid tumors

Y. Bang, J. W. Kim, Keun-Wook Lee, 2020, Clinical and translational science.

Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14‐01)

M. Ahn, Keunchil Park, J. Lee, 2017, Cancer.

The implication of FLT3 amplification for FLT targeted therapeutics in solid tumors

Joon-Oh Park, Keunchil Park, S. Park, 2016, OncoTarget.

A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer

Su Jin Lee, S. J. Lee, M. Ahn, 2021, Cancer research and treatment.

Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial

R. Cristescu, D. Sinn, W. Kang, 2022, Genome Medicine.

Comprehensive molecular and clinical characterization of Asian melanoma patients treated with anti-PD-1 antibody

K. Jang, Kyung Kim, Jeeyun Lee, 2019, BMC Cancer.

Efficacy of BRAF Inhibitors in Asian Metastatic Melanoma Patients: Potential Implications of Genomic Sequencing in BRAF-Mutated Melanoma12

W. Park, K. Jang, Kyung Kim, 2016, Translational oncology.

Retrospective multicenter study on the development of peripheral lymphocytosis following second‐line dasatinib therapy for chronic myeloid leukemia

Su Jin Lee, C. Jung, Hyeoung-Joon Kim, 2011, American journal of hematology.

A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13

Ha Yeon Lee, Sin-Ho Jung, J. Ahn, 2018, Cancer research and treatment : official journal of Korean Cancer Association.

Pemetrexed plus platinum versus pemetrexed alone in non-small cell lung cancer patients who have progressed after first-line EGFR TKIs.

J. Ahn, M. Ahn, Keunchil Park, 2015, Lung cancer.

Treatment outcomes and clinicopathologic characteristics of triple‐negative breast cancer patients who received platinum‐containing chemotherapy

J. Ahn, Keunchil Park, Yeon-Hee Park, 2009, International journal of cancer.

Extraosseous osteosarcoma: Single institutional experience in Korea

S. J. Lee, Joon-Oh Park, Jeeyun Lee, 2010, Asia-Pacific Journal of Clinical Oncology.

Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10-06).

I. Hwang, K. Jang, Jeeyun Lee, 2015, The oncologist.

A Korean multi-center, real-world, retrospective study of first-line pazopanib in unselected patients with metastatic renal clear-cell carcinoma

S. Park, H. Lim, Se-Hoon Lee, 2016, BMC Urology.

NTRK gene amplification in patients with metastatic cancer

Joon-Oh Park, Keunchil Park, S. Park, 2017 .

Direct analysis of aberrant glycosylation on haptoglobin in patients with gastric cancer

S. J. Lee, Joon-Oh Park, S. Park, 2016, Oncotarget.

Different subtypes of epithelioid sarcoma and their clinical implication: long‐term multi‐institutional experience with a rare sarcoma

Min Hwan Kim, Hyo Song Kim, K. Yoo, 2017, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experience

Su Jin Lee, I. Song, Hyung Joon Kim, 2012, The Korean journal of hepatology.

Effect of Cannabidiol Oil on Weight Loss in Diet-Induced Obese Mice: Validation Study

Doh-Kwan Kim, Shinn-Won Lim, Su Jin Lee, 2022, Journal of Korean Neuropsychiatric Association.

Inclusion of hemoglobin level in prognostic score provides better prognostic stratification in patients with acute promyelocytic leukemia (APL)

Su Jin Lee, Kihyun Kim, C. Jung, 2013, International Journal of Hematology.

Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series

S. Park, K. Yoo, S. Rha, 2015, BMC Cancer.

Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumors

S. J. Lee, Joon-Oh Park, M. Ahn, 2017, Investigational New Drugs.

Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study

Su Jin Lee, Yeon-Hee Park, S. Park, 2015, BMC Cancer.

Intrinsic resistance to sunitinib in patients with metastatic renal cell carcinoma

S. Park, I. Hwang, S. Lim, 2017, Asia-Pacific journal of clinical oncology.

Phase 1a study results investigating the safety and preliminary efficacy of ABL001 (NOV1501), a bispecific antibody targeting VEGF and DLL4 in metastatic gastrointestinal (GI) cancer.

Joon-Oh Park, S. Park, W. You, 2019, Journal of Clinical Oncology.

Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study

S. Park, K. S. Jung, H. Lim, 2017, Cancer research and treatment : official journal of Korean Cancer Association.

First-in-human phase I trial of anti-hepatocyte growth factor (HGF) antibody (YYB101) in refractory solid tumor patients.

Joon-Oh Park, D. Nam, S. Park, 2018 .

The Preoperative Role of Breast-specific Gamma Imaging for the Breast Cancer Patients: In Comparison with Conventional Imaging Modality

J. Lee, Sangmin Kim, Se Kyung Lee, 2010 .

A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13).

M. Jung, M. Ahn, Miso Kim, 2023, European journal of cancer.

Phase I trial and pharmacokinetic study of Tanibirumab, a fully human monoclonal antibody to the vascular endothelial growth factor receptor 2 in patients with refractory solid tumors.

Joon-Oh Park, M. Ahn, S. Park, 2015 .